Pdl biopharma, inc. (PDLI)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Sep'09Jun'09
Costs and Expenses

37,871

-

-

-

14,915

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues
Royalty revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

91,847

-

85,231

125,904

77,344

72,808

83,370

122,127

73,336

74,629

86,442

120,343

62,061

71,446

113,403

Interest revenue

-

-

0

0

-

83

754

751

749

776

6,051

5,460

5,457

5,503

8,594

7,343

8,964

7,606

9,096

8,966

10,534

13,260

13,076

12,613

9,071

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue

-

-

-

-

-

-

-

-

-

-

20,067

18,829

12,581

-

14,128

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licenses Revenue

-

-

-

-

-

-

-

-

-

-

-165

19,536

100

-

-127

327

-193

143

580

0

0

-

0

575

-

-

1,000

0

-

-

0

-

-

0

400

0

10,000

1,500

0

0

0

0

12,461

Revenues

5,995

26,422

44,165

-22,526

6,696

45,119

67,898

46,575

38,518

68,036

62,749

143,835

45,440

66,492

53,638

21,047

103,124

178,058

124,618

138,066

149,706

117,075

164,594

162,752

136,804

115,715

100,178

148,520

91,847

92,401

85,231

125,904

77,344

72,808

83,770

122,127

83,336

76,129

86,442

120,343

62,061

71,446

125,864

Operating expenses
Cost of Revenue

2,860

22,438

15,033

12,348

3,800

11,444

11,926

14,524

10,566

17,905

5,565

4,515

2,552

4,065

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

302

-

1,575

1,598

318

-

1,577

6,384

6,293

-

6,275

6,148

6,015

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Business Exit Costs

18,734

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,014

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

12,869

14,710

12,092

10,483

8,313

6,019

13,211

14,529

11,661

9,788

11,989

11,288

12,576

12,597

10,396

6,951

9,846

12,545

8,450

7,429

7,666

17,726

5,686

6,920

4,582

7,861

7,925

6,783

7,186

7,732

5,647

5,145

6,945

4,823

3,960

3,776

5,779

12,056

11,110

8,820

9,410

5,255

5,590

Selling and Marketing Expense

1,250

3,123

1,712

2,073

1,574

2,772

3,469

5,385

5,513

6,489

4,994

3,616

2,584

527

11

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and Development Expense

1,856

1,202

4,310

886

910

806

672

684

793

729

605

4,281

1,766

1,887

1,933

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of Intangible Assets, Finite-lived

-

-

0

0

-

-

0

152,330

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-

-

0

0

-

-19,198

302

-22,135

-600

-3,000

700

1,207

1,442

-5,799

2,083

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

546

2,959

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

34,722

27,388

-

11,620

31,157

171,701

34,226

38,162

30,128

31,055

26,935

74,160

20,983

9,910

9,846

-

8,450

7,429

-

-

-

-

-

-

-

-

7,186

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating loss from continuing operations

-31,876

-51,124

9,443

-49,914

-8,219

33,499

36,741

-125,126

4,292

29,874

32,621

112,780

18,505

-7,668

32,655

11,137

93,278

161,534

116,168

130,637

142,040

99,349

158,908

155,832

132,222

107,854

92,253

141,737

84,661

84,669

79,584

120,759

70,399

67,985

79,810

118,351

77,557

-28,427

75,332

111,523

52,651

66,191

120,274

Non-operating expense, net
Interest and other income, net

513

1,046

1,460

1,650

1,874

1,194

1,581

1,376

1,914

933

238

276

212

184

162

129

113

74

87

121

86

108

75

82

50

-3,709

53

60

3,838

-1,627

1,867

428

90

131

130

157

175

-

-

-

-

-

-

Interest and other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

167

90

-

-

-

Interest expense

474

2,454

3,011

2,984

2,955

2,895

2,866

2,811

3,585

5,139

5,096

5,015

4,971

4,743

4,513

4,461

4,550

5,349

5,901

7,199

8,610

9,441

9,387

9,858

10,525

6,702

6,118

6,051

6,000

5,950

6,514

7,872

8,700

8,161

9,007

9,780

9,154

9,514

9,928

11,560

12,527

3,105

3,357

Unrealized Gain (Loss) on Investments

-13,797

-

-27,378

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Business Combination, Bargain Purchase, Gain Recognized, Amount

-

-

-

-

-

-

-

-

-

-

2,276

6,271

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (Loss) on Investments

-

-

3,476

45,487

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (Loss) on Extinguishment of Debt

-606

-

-3,900

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-6,143

0

0

0

0

-

-

-

-

-

-

-766

-

-

-2,354

-16,327

-

323

1,195

Total non-operating expense, net

-14,364

12,355

-29,353

44,153

-1,081

-937

-1,285

-1,435

-1,671

1,108

-7,134

1,532

-4,759

-6,912

-4,351

-4,332

-4,437

1,175

-5,814

-7,078

-8,524

-9,333

-9,312

-9,776

-16,618

-10,411

-6,065

-5,991

-2,162

-7,577

-4,647

-7,444

-8,610

-8,030

-8,877

-10,389

-8,979

-20,877

-12,115

-27,797

80

214

310

Loss from continuing operations before income taxes

-46,240

-38,769

-19,910

-5,761

-9,300

32,562

35,456

-126,561

2,621

30,982

25,487

114,312

13,746

-14,580

28,304

6,805

88,841

162,709

110,354

123,559

133,516

90,016

149,596

146,056

115,604

97,443

86,188

135,746

82,499

77,092

74,937

113,315

61,789

59,955

70,933

107,962

68,578

-36,777

63,217

83,726

40,204

63,623

118,422

Income tax benefit from continuing operations

-14,473

990

-1,944

-1,247

-848

16,283

9,900

-14,265

1,019

8,646

4,755

53,873

6,552

-4,300

14,400

2,657

32,954

62,135

40,895

45,295

49,018

34,945

47,361

54,001

42,721

36,351

29,963

42,004

29,028

27,684

26,362

39,813

21,605

21,013

25,017

37,976

24,033

-12,317

23,028

33,588

14,197

17,217

41,185

Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest

-31,767

-

-

-

-8,452

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-32,011

-54,828

-17,966

-4,514

6,617

16,279

25,556

-112,296

1,602

22,336

20,732

60,439

7,194

-10,280

13,904

4,148

55,887

-

69,459

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax

75

-

-

-

18,689

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued Operation, Tax Effect of Discontinued Operation

319

-

-

-

3,620

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax

-244

-

-

-

15,069

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Noncontrolling Interest

-288

60

-182

-95

-63

0

0

0

0

0

0

0

-47

56

-3

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-31,723

-54,888

-17,784

-4,419

6,680

16,279

25,556

-112,296

1,602

22,336

20,732

60,439

7,241

-10,336

13,907

4,148

55,887

100,574

69,459

78,264

84,498

55,071

102,235

92,055

72,883

61,092

56,225

93,742

53,471

49,408

48,575

73,502

40,184

38,942

45,916

69,986

44,545

-24,460

40,189

50,138

26,007

46,406

77,237

Income (Loss) from Continuing Operations, Per Basic Share

-0.26

-

-

-

-0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings Per Share [Abstract]
Basic (in Dollars per Share)

-0.26

-0.44

-0.16

-0.04

0.05

0.10

0.18

-0.76

0.01

0.14

0.14

0.39

0.04

-0.06

0.08

0.03

0.34

0.62

0.42

0.48

0.52

0.35

0.64

0.57

0.48

0.44

0.40

0.67

0.38

0.35

0.35

0.53

0.29

0.28

0.33

0.50

0.32

-0.23

0.32

0.42

0.22

0.39

-

Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share

0.00

-

-

-

0.12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income per diluted share (in Dollars per Share)

-0.26

-0.44

-0.16

-0.04

0.05

0.10

0.18

-0.76

0.01

0.14

0.14

0.39

0.04

-0.06

0.08

0.03

0.34

0.64

0.42

0.47

0.50

0.29

0.61

0.52

0.44

0.32

0.36

0.62

0.36

0.32

0.32

0.52

0.29

0.24

0.28

0.38

0.25

-0.15

0.24

0.30

0.15

0.29

-

Income (Loss) from Continuing Operations, Per Diluted Share

-0.26

-

-

-

-0.07

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share

0.00

-

-

-

0.12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding
Basic (in Shares)

122,896

114,454

112,986

118,285

128,799

141,109

143,171

146,923

151,473

151,031

151,146

155,654

163,745

163,872

163,856

163,791

163,701

163,611

163,560

163,544

162,829

161,174

160,268

160,256

151,198

139,879

139,848

139,825

139,816

279,306

139,715

139,683

139

139,682

139,680

139,650

139,640

-246,628

127,479

119,536

119

119,411

119,357

Diluted (in Shares)

122,896

114,454

112,986

118,285

128,799

138,950

144,224

146,923

152,579

152,325

152,317

156,394

163,992

164,619

164,285

164,029

163,835

154,678

163,742

165,384

170,412

183,747

166,894

177,228

164,571

181,454

154,593

152,224

149,101

293,632

149,626

142,213

140

166,731

167,019

186,060

189,954

-345,084

172,217

173,398

184

168,576

169,566

Cash dividends declared per common share (in Dollars per Share)

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.05

0.05

0.00

0.00

0.00

0.60

0.00

0.00

0.00

0.60

0.00

0.00

0.00

0.60

0.00

0.00

0.00

0.60

0.00

0.00

0.00

0.60

-0.50

0.50

0.00

1.00

0.00

-

Product Revenue [Member]
Revenue from Contract with Customer, Including Assessed Tax

5,985

40,927

20,345

17,837

6,726

25,976

24,387

31,761

23,324

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Queen et al. patents [Member]
Revenues

0

0

0

6

3

2

533

1,218

2,783

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquired rights [Member]
Revenues

-

-

23,865

-40,399

-

19,139

42,184

12,842

11,091

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and other [Member]
Revenues

10

3

-45

30

-33

-81

40

3

571

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-